Pr Zheng - Biostar Pharmaceuticals Chief Scientist
| BSPMDelisted Stock | USD 0.01 0.00 0.00% |
Insider
Pr Zheng is Chief Scientist of Biostar Pharmaceuticals
| Age | 55 |
| Phone | 86 29 3368 6638 |
| Web | https://biostarpharmaceuticals.com |
Biostar Pharmaceuticals Management Efficiency
The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0266 %, meaning that it created $0.0266 on every $100 dollars invested by stockholders. Biostar Pharmaceuticals' management efficiency ratios could be used to measure how well Biostar Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Tyvin MD | Shuttle Pharmaceuticals | 76 | |
| John Minardo | Ironwood Pharmaceuticals | 48 | |
| Yifat Esq | Kamada | 47 | |
| Jason Rickard | Ironwood Pharmaceuticals | 53 | |
| Sravan Emany | Ironwood Pharmaceuticals | 46 | |
| Mira Jung | Shuttle Pharmaceuticals | 75 | |
| A MBA | Cumberland Pharmaceuticals | 66 | |
| Albert Bolles | Lifecore Biomedical | 66 | |
| Beth Calitri | Ironwood Pharmaceuticals | N/A | |
| Michael Starkweather | Shuttle Pharmaceuticals | 40 | |
| Michael Hoek | Shuttle Pharmaceuticals | 64 | |
| Aaron Perlitsh | Lifecore Biomedical | N/A | |
| Cindy Patton | Cumberland Pharmaceuticals | 71 | |
| Ariella Raban | Kamada | 48 | |
| Adam Mostafa | Cumberland Pharmaceuticals | 44 | |
| Anatoly MD | Shuttle Pharmaceuticals | 80 | |
| CSC MD | Shuttle Pharmaceuticals | 57 | |
| Eran Nir | Kamada | 51 | |
Management Performance
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 |
Biostar Pharmaceuticals Leadership Team
Elected by the shareholders, the Biostar Pharmaceuticals' board of directors comprises two types of representatives: Biostar Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Biostar. The board's role is to monitor Biostar Pharmaceuticals' management team and ensure that shareholders' interests are well served. Biostar Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Biostar Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Zhenghong Wang, Chief Officer | ||
| Pr Zheng, Chief Scientist | ||
| Ronghua Wang, Chairman, CEO and President Chairman of Aoxing Pharmaceutical Inc, CEO of Aoxing Pharmaceutical Inc and President of Aoxing Pharmaceutical Inc | ||
| Xiaojuan Zhai, Chief Officer | ||
| Shuang Gong, Secretary of Board |
Biostar Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Biostar Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0266 | ||||
| Return On Asset | 0.0425 | ||||
| Profit Margin | 2.94 % | ||||
| Operating Margin | 8.76 % | ||||
| Current Valuation | 316.46 K | ||||
| Shares Outstanding | 2.64 M | ||||
| Number Of Shares Shorted | 170.44 K | ||||
| Price To Book | 0.01 X | ||||
| Price To Sales | 0.0001 X | ||||
| Revenue | 317.79 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in Biostar Pink Sheet
If you are still planning to invest in Biostar Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biostar Pharmaceuticals' history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |